NCT04478279 2026-02-09A Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsSapience TherapeuticsPhase 1/2 Active not recruiting125 enrolled
NCT01294735 2012-08-15Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)Merck Sharp & Dohme LLCPhase 1 Completed19 enrolled